Beatriz Gros
@Bealoquebea
Gastroenterologist #IBD passionate. Help others grow their abilities and celebrate life. https://t.co/4V0xhhdIti
ID:358763829
https://ibd-eii.com/ 20-08-2011 13:21:18
8,8K Tweets
4,7K Followers
763 Following
Fantastic overview of H2H trials in IBD. More on the way this DDW. Great work Beatriz Gros
I am so thrilled that our study defining mechanisms of #PerianalFistula in #Crohns disease is now out in Med by Cell Press . Thank you to Judy Cho + team, Mount Sinai IBD Center MountSinai Pathology SinaiMSTP , and the patients who made this possible
doi.org/10.1016/j.medj…
Beatriz Gros Fernando Gomollón Sociedad Española de Patología Digestiva (SEPD) Ashkan Rezazadeh MD Aline Charabaty, MD, FACG, AGAF Seb Y-ECCO ignacio catalan Guillermo Veitia V. GETECCU Joseph Sleiman, MD My main skill is appreciation of talent and hard work in others.
Your website is amazing!
Beatriz Gros Fernando Gomollón Sociedad Española de Patología Digestiva (SEPD) Ashkan Rezazadeh MD Aline Charabaty, MD, FACG, AGAF Seb Y-ECCO ignacio catalan Guillermo Veitia V. GETECCU Joseph Sleiman, MD Amazing summary.. each one is for keeps.. thanks for sharing!!
First-line infliximab #biosimilar in paediatric Crohn's disease cost effective! See our latest paper
onlinelibrary.wiley.com/doi/10.1111/ap…
Dermal injury drives a skin to gut axis that disrupts the intestinal microbiome and intestinal immune homeostasis in mice Nature Communications nature.com/articles/s4146…
Sometimes I get asked about stem-cell transplantation (SCT) for IBD
☑️The Lancet Gastroenterology & Hepatology 👇🏾
🟢bold idea + brave pts + investigators.
🔴 risk of SCT >>>> risk of IBD
🔴SCT not better than standard tx
🔴don’t trade morbidity for mortality?
thelancet.com/journals/langa…
Welcome Y-ECCO to USA & #EBMed
Happy to see Youth committee leads here as travel grant awardees Maria Manuela Estevinho & Virginia Solitano
We need more interactions across the ponds & beyond Seb Lumír Kunovský Paula Sousa my_UEG Aline Charabaty, MD, FACG, AGAF Ashkan Rezazadeh MD Beatriz Gros ignacio catalan
Fascinating study on Vedolizumab mechanism of action in Ulcerative colitis in Science Immunology by Mehandru Lab @MountSinai
Saved for reading after the weekend!⛵️
👇🏻👇🏻👇🏻
Great diet trial published yesterday!
294 people with #IrritableBowelSyndrome #IBS
1⃣Low FODMAP plus BDA/NICE (76% responders)
2⃣Low carbohydrate (71%)
3⃣Optimised medical (58%)
P=0.023
Paper Magnus Simren in The Lancet Gastroenterology & Hepatology
thelancet.com/journals/langa…
#IBS AwarenessMonth #CFGI24
🔸What’s the pathophysiology of Portal Hypertension?
🔹Which therapeutic options are available or in the pipeline?
🔸Can we optimize the research in this field?
✅Answer these, and other, questions in our latest review now available The Lancet Gastroenterology & Hepatology
🆓 authors.elsevier.com/a/1ixqA8nByr8u…